Skip to main content
. 2020 Dec 21;64(1):26–41. doi: 10.1021/acs.jmedchem.0c00931

Figure 6.

Figure 6

Design of dual GSK-3β/AK inhibitors. Compound 9, able to bind to both GSK-3β and hAK in the micromolar range of concentrations, has been obtained through a series of modifications of compound 8, developed by the same authors, that fails to bind to hAK.